Advertisement
KPTI vs KRYS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KPTI is a StrongBuy and KRYS is a Buy.
KPTI in +83.29% Uptrend, rising for three consecutive days on October 29, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where KPTI advanced for three days, in 222 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KPTI as a result. In 85 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for KPTI turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 44 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KPTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
KPTI broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for KPTI entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.004) is normal, around the industry mean (3.498). P/E Ratio (-0.004) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.226) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. KPTI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KPTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
KRYS sees its Stochastic Oscillator climbs out of oversold territory
On October 28, 2026, the Stochastic Oscillator for KRYS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 54 instances where the indicator left the oversold zone. In 43 of the 54 cases the stock moved higher in the following days. This puts the odds of a move higher at over 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +1.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where KRYS advanced for three days, in 258 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
KRYS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KRYS as a result. In 78 of 105 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for KRYS turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In 41 of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KRYS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for KRYS entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 9 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. KRYS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.553) is normal, around the industry mean (3.498). P/E Ratio (36.382) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (23.202) is also within normal values, averaging (440.869).
KPTI | KRYS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 95 | 26 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 43 Fair valued | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 9 | |
SMR RATING 1..100 | 100 | 46 | |
PRICE GROWTH RATING 1..100 | 99 | 54 | |
P/E GROWTH RATING 1..100 | 5 | 20 | |
SEASONALITY SCORE 1..100 | 50 | 2 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
KPTI's Valuation (43) in the Biotechnology industry is somewhat better than the same rating for KRYS (91) in the Pharmaceuticals Major industry. This means that KPTI’s stock grew somewhat faster than KRYS’s over the last 12 months.
KRYS's Profit vs Risk Rating (9) in the Pharmaceuticals Major industry is significantly better than the same rating for KPTI (100) in the Biotechnology industry. This means that KRYS’s stock grew significantly faster than KPTI’s over the last 12 months.
KRYS's SMR Rating (46) in the Pharmaceuticals Major industry is somewhat better than the same rating for KPTI (100) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than KPTI’s over the last 12 months.
KRYS's Price Growth Rating (54) in the Pharmaceuticals Major industry is somewhat better than the same rating for KPTI (99) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than KPTI’s over the last 12 months.
KPTI's P/E Growth Rating (5) in the Biotechnology industry is in the same range as KRYS (20) in the Pharmaceuticals Major industry. This means that KPTI’s stock grew similarly to KRYS’s over the last 12 months.
| KPTI | KRYS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | N/A |
| Stochastic ODDS (%) | 2 days ago 83% | 2 days ago 80% |
| Momentum ODDS (%) | 2 days ago 89% | 2 days ago 74% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 73% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 89% | 2 days ago 70% |
| Advances ODDS (%) | 14 days ago 86% | 2 days ago 79% |
| Declines ODDS (%) | 2 days ago 90% | 20 days ago 71% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 78% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 67% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KPTI’s FA Score shows that 1 FA rating(s) are green while KRYS’s FA Score has 2 green FA rating(s).
- KPTI’s FA Score: 1 green, 4 red.
- KRYS’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KPTI’s TA Score shows that 3 TA indicator(s) are bullish while KRYS’s TA Score has 3 bullish TA indicator(s).
- KPTI’s TA Score: 3 bullish, 5 bearish.
- KRYS’s TA Score: 3 bullish, 4 bearish.
Price Growth
KPTI (@Biotechnology) experienced а -80.29% price change this week, while KRYS (@Biotechnology) price change was +0.48% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
KPTI is expected to report earnings on Nov 16, 2026.
KRYS is expected to report earnings on Mar 01, 2027.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TYLD | 25.42 | N/A | N/A |
| Cambria Tactical Yield ETF (TYLD) | |||
| DFMC | 58.52 | -0.25 | -0.43% |
| U.S. Micro Cap Portfolio ETF (DFMC) | |||
| NANR | 83.71 | -0.96 | -1.13% |
| State Street SPDR S&P North American Natural Resources ETF (NANR) | |||
| EWY | 139.18 | -2.92 | -2.05% |
| iShares MSCI South Korea ETF (EWY) | |||
| SOEZ | 14.43 | -0.55 | -3.68% |
| Franklin Solana ETF | |||